FALLERINI, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 3.698
NA - Nord America 2.487
AS - Asia 430
AF - Africa 37
OC - Oceania 9
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.671
Nazione #
US - Stati Uniti d'America 2.476
IT - Italia 1.048
GB - Regno Unito 770
IE - Irlanda 668
SE - Svezia 278
RU - Federazione Russa 234
DE - Germania 182
CN - Cina 179
FR - Francia 160
FI - Finlandia 104
UA - Ucraina 95
SG - Singapore 92
VN - Vietnam 48
ES - Italia 44
CI - Costa d'Avorio 35
TR - Turchia 29
IN - India 25
BE - Belgio 24
CZ - Repubblica Ceca 23
CH - Svizzera 14
IR - Iran 14
NL - Olanda 13
CA - Canada 9
HK - Hong Kong 9
AU - Australia 8
PL - Polonia 6
BG - Bulgaria 5
PK - Pakistan 5
AT - Austria 4
DK - Danimarca 4
EU - Europa 4
JP - Giappone 4
LV - Lettonia 4
MK - Macedonia 4
LK - Sri Lanka 3
PH - Filippine 3
RO - Romania 3
BR - Brasile 2
CL - Cile 2
CY - Cipro 2
GR - Grecia 2
IL - Israele 2
KG - Kirghizistan 2
PT - Portogallo 2
QA - Qatar 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AL - Albania 1
AZ - Azerbaigian 1
BY - Bielorussia 1
EC - Ecuador 1
EG - Egitto 1
ID - Indonesia 1
JM - Giamaica 1
JO - Giordania 1
KR - Corea 1
LT - Lituania 1
MD - Moldavia 1
MM - Myanmar 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
TM - Turkmenistan 1
ZA - Sudafrica 1
Totale 6.671
Città #
Southend 705
Dublin 650
Chandler 311
Fairfield 300
Ashburn 260
Siena 259
Ann Arbor 131
Woodbridge 131
Houston 116
Seattle 115
Cambridge 110
Wilmington 96
Florence 93
Helsinki 87
New York 86
Princeton 79
Jacksonville 73
Milan 67
Singapore 65
Menlo Park 62
Dong Ket 47
Beijing 44
Rome 38
Shanghai 36
Abidjan 35
Málaga 34
San Diego 31
Boardman 30
Dearborn 27
Washington 24
Izmir 21
Nanjing 20
San Mateo 19
Brno 18
Fremont 18
Los Angeles 18
Munich 18
Moscow 16
Brussels 15
Chicago 14
London 14
Nuremberg 13
Guangzhou 12
Aachen 11
Comun Nuovo 10
Lancaster 10
Hyderabad 9
Nanchang 9
Redwood City 9
Dallas 8
Naples 8
Waanrode 8
Brescia 7
Carrara 7
Hong Kong 7
Norwalk 7
Shenyang 7
Zurich 7
Anagni 6
Bergamo 6
Bologna 6
Catania 6
Hebei 6
Jinan 6
Lappeenranta 6
Livorno 6
Paris 6
Rubano 6
Tianjin 6
Catanzaro 5
Grosseto 5
Migliarino 5
Pavia 5
Phoenix 5
Pisa 5
Prato 5
Salerno 5
Sofia 5
Stockholm 5
Toronto 5
Verona 5
Zhengzhou 5
Basel 4
Brindisi 4
Cagliari 4
Casalecchio di Reno 4
Fiesole 4
Genova 4
Indore 4
Melbourne 4
Padova 4
Poggibonsi 4
Riga 4
Saint-Fons 4
Santa Clara 4
Sorbolo 4
Vienna 4
Zanjan 4
Amsterdam 3
Bangalore 3
Totale 4.683
Nome #
Omic Approach in Non-Smoker Female with Lung Squamous Cell Carcinoma Pinpoints to Germline Susceptibility and Personalized Medicine 260
Coffin-Siris and Nicolaides-Baraitser syndromes are a common well recognizable cause of intellectual disability. 250
iPSC-derived neurons profiling reveals GABAergic circuit disruption and acetylated α-tubulin defect which improves after iHDAC6 treatment in Rett syndrome 246
Clonality analysis of immunoglobulin gene rearrangement by next-generation sequencing in endemic burkitt lymphoma suggests antigen drive activation of bcr as opposed to sporadic burkitt lymphoma 219
Potentially treatable disorder diagnosed post Mortem by exome analysis in a boy with respiratory distress 206
Low-level TP53 mutational load antecedes clonal expansion in chronic lymphocytic leukaemia 200
Alport syndrome: impact of digenic inheritance in patients management 196
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 190
Genetic mechanisms of critical illness in COVID-19 190
Evidence of digenic inheritance in Alport syndrome 189
null 182
Non-collagen genes role in digenic Alport syndrome 179
Personalized therapy in a GRIN1 mutated girl with intellectual disability and epilepsy 176
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 176
Advances in Alport syndrome diagnosis using next-generation sequencing 158
Prognostic Value of Glomerular Collagen IV Immunofluorescence Studies in Male Patients with X-Linked Alport Syndrome 156
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 151
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 143
null 140
A Unique Patient Presenting with Concomitant Klinefelter Syndrome, Alport Syndrome and Craniopharyngioma. 138
Unbiased Next Generation Sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases 129
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 124
Pathogen-sugar interactions revealed by universal saturation transfer analysis 119
Mapping the human genetic architecture of COVID-19 118
Assessment of haptoglobin alleles in autism spectrum disorders 112
A first update on mapping the human genetic architecture of COVID-19 107
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 101
An explainable model of host genetic interactions linked to COVID-19 severity 96
Detection of cryptic mosaicism in X-linked alport syndrome prompts to re-evaluate living-donor kidney transplantation 94
WES profiling of COVID-19 93
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 89
A pilot study of next generation sequencing–liquid biopsy on cell-free DNA as a novel non-invasive diagnostic tool for Klippel–Trenaunay syndrome 88
RB1 Germline Variant Predisposing to a Rare Ovarian Germ Cell Tumor: A Case Report 88
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 87
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 84
Cell-free DNA next-generation sequencing liquid biopsy as a new revolutionary approach for arteriovenous malformation 81
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 80
null 75
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality 75
SELP Asp603Asn and severe thrombosis in COVID-19 males 74
Exome sequencing in 200 intellectual disability/autistic patients: new candidates and atypical presentations 72
MET somatic activating mutations are responsible for lymphovenous malformation and can be identified using cell-free DNA next generation sequencing liquid biopsy 71
Protective role of a TMPRSS2 variant on severe COVID-19 outcome in young males and elderly women 69
Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism 68
Human CRY1 variants associate with attention deficit/hyperactivity disorder 65
Spondyloocular Syndrome: a novel XYLT2 variant with description of the neonatal phenotype 64
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 59
New candidates for autism/intellectual disability identified by whole-exome sequencing 59
SLC12A2 variants cause a neurodevelopmental disorder or cochleovestibular defect 56
Private somatic mutations identified with liquid biopsy lead tumor progression in solid cancers 51
X-Linked Alport Syndrome in Women: Genotype and Clinical Course in 24 Cases 49
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 46
Corrigendum: Exome Sequencing in BRCA1-2 Candidate Familias: The Contribution of Other Cancer Susceptibility Genes (Front. Oncol., (2021), 11, 10.3389/fonc.2021.649435) 43
Heterozygosity for Neuronal Ceroid Lipofuscinosis predisposes to Bipolar Disorder 41
Nosological and Theranostic Approach to Vascular Malformation through cfDNA NGS Liquid Biopsy 37
Vestibular and audiological findings in the Alport syndrome 37
Exome sequencing in BRCA1-2 candidate familias: the contribution of other cancer susceptibility genes. 35
Clinical and molecular characterization of COVID-19 hospitalized patients 35
Whole-genome sequencing reveals host factors underlying critical COVID-19 34
The microRNA processor DROSHA is a candidate gene for a severe progressive neurological disorder 31
Urine-derived podocytes-lineage cells: A promising tool for precision medicine in Alport Syndrome 31
Sporadic hereditary motor and sensory neuropathies: Advances in the diagnosis using next generation sequencing technology 29
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 27
New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells 27
Host genetic basis of COVID-19: from methodologies to genes 23
Autism Spectrum Disorders: Analysis of Mobile Elements at 7q11.23 Williams-Beuren Region by Comparative Genomics 22
HLA-DPB1*13:01 associates with enhanced, and KIR2DS4*001 with diminished protection from developing severe COVID-19 16
Understanding the new BRD4-related syndrome: Clinical and genomic delineation with an international cohort study 15
Case report: PIK3CA somatic mutation leading to Klippel Trenaunay Syndrome and multiple tumors 14
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 12
A Solve-RD ClinVar-based reanalysis of 1522 index cases from ERN-ITHACA reveals common pitfalls and misinterpretations in exome sequencing 12
FOXG1 variants can be associated with milder phenotypes than congenital Rett syndrome with unassisted walking and language development 9
Human leukocyte antigen variants associate with BNT162b2 mRNA vaccine response 9
Host genetics and COVID-19 severity: increasing the accuracy of latest severity scores by Boolean quantum features 7
Rare coding variation provides insight into the genetic architecture and phenotypic context of autism 7
Twist exome capture allows for lower average sequence coverage in clinical exome sequencing 6
Structural variant calling and clinical interpretation in 6224 unsolved rare disease exomes 5
CYP19A1 mediates severe SARS-CoV-2 disease outcome in males 5
Effects of the Rho GTPase-activating toxin CNF1 on fibroblasts derived from Rett syndrome patients: A pilot study 3
Totale 6.960
Categoria #
all - tutte 28.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.103


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020595 0 0 35 86 68 62 69 90 67 48 31 39
2020/2021939 27 51 16 60 52 51 75 79 116 184 123 105
2021/2022982 97 91 54 83 50 42 48 45 56 92 116 208
2022/20231.427 74 133 137 136 107 254 165 154 100 62 65 40
2023/20241.470 64 51 167 78 70 345 390 71 14 65 56 99
2024/2025642 162 133 347 0 0 0 0 0 0 0 0 0
Totale 6.960